)
Edge17 Oct 2025
A Castle in the Sky: The Story of Oracle
Oracle's journey from database innovator to disciplined enterprise backbone, now shaping the AI buildout with a standardized cloud infrastructure.
Biotest (BIO3) investor relations material
Biotest Q1 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q1 2025 earnings summary12 May, 2025
Executive summary
Q1 2025 revenue fell 42.3% year-over-year to €124.2 million, mainly due to a sharp drop in technology transfer revenue from Grifols and lower product sales.
EBIT declined to €-23.0 million from €52.8 million in Q1 2024, reflecting reduced sales and lower earnings from technology services.
Net loss after taxes was €-21.4 million, compared to a profit of €29.5 million in the prior year period.
Product sales of human albumin and Yimmugo® increased by 17.0% and 10.2% respectively, despite overall product sales decline.
Biotest completed Phase III trials for fibrinogen and advanced regulatory filings in Europe and the US.
Financial highlights
Revenue: €124.2 million (Q1 2025) vs €215.2 million (Q1 2024), down 42.3%.
EBIT: €-23.0 million (Q1 2025) vs €52.8 million (Q1 2024).
Net loss: €-21.4 million (Q1 2025) vs net income €29.5 million (Q1 2024).
EPS: €-0.55 (Q1 2025) vs €0.74 (Q1 2024).
Operating cash flow: €-58.1 million (Q1 2025) vs €-11.6 million (Q1 2024).
Outlook and guidance
2025 sales expected to decline mid single-digit percent from 2024, reflecting lower technology transfer revenue.
EBIT forecasted between €-55.0 million and €-75.0 million for 2025.
ROCE expected between -3% and -7%; operating cash flow anticipated to remain negative.
Risks include Middle East conflict, potential US tariffs on EU pharmaceuticals, and FDA response delays.
Explain the delay of Intratect release.
Assess impact of US tariffs on Biotest.
When is Trimodulin market entry expected?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
Company Research17 Oct 2025
Beneath the Surface: A Conversation with Epiroc CEO Helena Hedblom
Legacy, innovation, and leading one of Sweden's most influential industrial companies into a new era.
)
Investor Relations14 Oct 2025
Boost Your Earnings Season Strategy With Real‑Time Alerts
Quartr Pro provides real time alerts, trend analysis and live coverage, giving analysts and investors instant insights to act faster in earnings.
Frequently asked questions
Biotest Aktiengesellschaft is a German-based company that specializes in the development, production, and marketing of plasma proteins and biological drugs. The company’s primary focus areas include clinical immunology, hematology, and intensive care medicine. Biotest’s product portfolio includes immunoglobulins, coagulation factors, and albumins, which are derived from human blood plasma and are utilized in treating immune and hematopoietic system disorders. Additionally, the company engages in the development of monoclonal antibodies for treating conditions such as cancer of plasma cells and systemic lupus erythematosus. The company is headquartered in Dreieich, Germany, and its shares are listed on the Frankfurt Stock Exchange.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage